ACM
HOOK

ADAR1 Capital Management’s HOOKIPA Pharma HOOK Stock Holding History

ADAR1 Capital Management’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,000
Closed -$35.6K – 291
2024
Q1 		$35.6K Buy
+5,000
New +$35.6K 0.01% 200

Other funds holding HOOK

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ADAR1 Capital Management's HOOK Position: Q2 2024 in Review

ADAR1 Capital Management sold out of HOOKIPA Pharma (HOOK) in Q2 2024, closing a stake of 5,000 shares — an estimated $35.6K sold.

ADAR1 Capital Management first reported a position in HOOK in Q1 2024 and held it in 1 quarter. The position peaked at $35.6K in Q1 2024. 40 funds tracked by Wall St. Rank hold HOOK as of Q2 2024.

  • ADAR1 Capital Management reported no remaining HOOKIPA Pharma position as of Q2 2024 after selling out during the quarter.
  • ADAR1 Capital Management sold 5,000 HOOKIPA Pharma shares in Q2 2024, an estimated $35.6K.
  • ADAR1 Capital Management first reported a position in HOOKIPA Pharma in Q1 2024 and held it in 1 quarter.
  • ADAR1 Capital Management's HOOKIPA Pharma position peaked at $35.6K in Q1 2024.
  • 40 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q2 2024.

Based on ADAR1 Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.